Cannabis is a flowering plant genus with a long history of use, with people consuming it due to the therapeutic and medical benefits it has. Its social and spiritual applications are also well recognized. The three prevalent species are Cannabis sativa, Cannabis indica, and Cannabis ruderalis. The majority of cultivars developed now are hybrids that combine characteristics of two or more of these primary species.




Momentum in the Legalisation of Cannabis


Furthermore, medical cannabis legalization is gaining traction around the world. The increasing recognition that the product which was once considered to be a taboo may have a variety of legitimate medicinal benefits and therapeutic applications is driving this trend. In recent years, medical hemp has received a lot of attention all over the world. As indicated by a growing number of countries and jurisdictions allowing its use for particular medical purposes, the use and acceptance of medical C. Sativa continues to expand. The worldwide cannabis market was estimated at USD 43.72 billion in 2022 and is expected to increase at a CAGR of 34.03% from USD 57.18 billion in 2023 to USD 444.34 billion by 2030.


Medical Cannabis in India


When it comes to the hemp business, India is a sleeping giant. Our country has had cannabis legislation in place since the 1980s when the US administration put pressure on us to crack down on the drug. Even after that, we have a very strong policy called the NDPS Policy, and we have the NDPS Act and Rules of 1985 to enforce that policy. Our Indian government has been quite supportive and clear on the regulations governing the development of medical cannabis-related drugs. The NDPS legislation contains numerous clauses that enable the industrial, medical, and scientific usage of cannabis. 


At the same time, our country, India, is quite comparable to the United States, where cannabis is officially prohibited but states have been allowed latitude. Section 8 of the NDPS Act, when combined with Section 10 ensures that state government can create its own rules governing cannabis cultivation, warehousing, processing, and interstate export and import. 


In the case of Uttarakhand, which was the first state to authorize cannabis production for industrial reasons, the 0.3% THC limit in THC oils has been a source of conflict and has hindered the business in its early stages. Because THC oils are present in the plants due to high UV index and high humidity, India, as an equatorial country, cannot support low THC cannabis farming. 


The legislation enacted in Uttarakhand was mostly based on the 2015 United States Farm Bill. Despite the fact that the state proceeded proactively, it failed to adopt and implement the UNODC guidelines on cannabis analysis and distinction.  According to UNODC recommendations, there is a way for distinguishing between pharmacological and fiber cannabis. 



THC oil and its future


The way forward is to overcome this knowledge and communication gap by having or establishing a think tank with experts or an expert-level group of bureaucrats, legislators, and company holders.


So that business owners can successfully express their on-the-ground realities as well as their on-the-ground difficulties. At the same time, it provides a platform for legislators and bureaucrats to grasp the situation on the ground faced by enterprises and how to best assist them, as well as to draft regulations that can aid in the advancement of the hemp industry in India.


A think tank, comparable to NITI-AAYOG, or an expert-level think tank that basically makes recommendations that help the country, lawmakers, and businesses all together in building a proper hemp sector in India and to smoothen out the process of buy thc oil online India.

Leave a comment
Note: HTML is not translated!